Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013

  Regeneron to Report First Quarter 2013 Financial and Operating Results and
               Host Conference Call and Webcast on May 3, 2013

PR Newswire

TARRYTOWN, N.Y., April 11, 2013

TARRYTOWN, N.Y., April 11, 2013 /PRNewswire/ --Regeneron Pharmaceuticals,
Inc. (NASDAQ: REGN)  today announced that it will report its first quarter
2013 financial and operating results on Friday, May 3, 2013, before the U.S.
financial markets open. The Company will host a conference call and
simultaneous webcast at 8:30 AM Eastern Time that day.

Conference Call Information
To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355
(International). A link to the webcast may be accessed from the 'Events and
Presentations' page of Regeneron's website at www.regeneron.com. A replay of
the conference call and webcast will be archived on the Company's website and
will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in
Tarrytown, New York that discovers, invents, develops, manufactures, and
commercializes medicines for the treatment of serious medical conditions.
Regeneron markets medicines for eye diseases, colorectal cancer, and a rare
inflammatory condition and has product candidates in development in other
areas of high unmet medical need, including hypercholesterolemia, oncology,
rheumatoid arthritis, asthma, and atopic dermatitis. For additional
information about the company, please visit www.regeneron.com.

Contact Information:
Michael Aberman, M.D.    Peter Dworkin
Investor Relations       Corporate
                              Communications
914-847-7799                914.847.7640 
michael.aberman@regeneron.com peter.dworkin@regeneron.com


SOURCE Regeneron Pharmaceuticals, Inc.

Website: http://www.regeneron.com